Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study
GlaxoSmithKline
Jonathan D C Ross; Janet Wilson; Kimberly A Workowski; Stephanie N Taylor; David A Lewis; Sally Gatsi; William Flight; Nicole E Scangarella-Oman; Charles Jakielaszek; Dan Lythgoe; Marcy Powell; Salim Janmohamed; Judith Absalon; Caroline Perry